ECG Leadwires: Disposable Versus Cleaned, Reusable (ECG LW)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Null hypothesis: (1) there is no difference in rates of ICU-acquired infection based on using disposable or cleaned, reusable ECG leadwires and (2) In cardiac surgical telemetry floors, there is no difference in false or nuisance sightings or crisis calls based on using disposable or cleaned, reusable ECG leadwires.
| Condition | Intervention |
|---|---|
|
Intensive Care Patients Cardiac Surgical Telemetry Patients |
Device: Disposable ECG leadwires; 5 and 6 lead sets Other: No intervention |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Prevention |
| Official Title: | ECG Leadwires: Do Disposable Leadwires Reduce the Incidence of Bacterial Infections in ICU Patients and Provide Adequate Signaling in Stepdown/Telemetry Environment Compared to Cleaned Reusable ECG Leadwires? |
- Blood stream infection [ Time Frame: 7 months ] [ Designated as safety issue: No ]culture findings
- false/nuisance alarms [ Time Frame: 4 months ] [ Designated as safety issue: Yes ]alarms generated by ECG tracings due to various causes (leads off, leads crimped, etc)
| Estimated Enrollment: | 1000 |
| Study Start Date: | September 2011 |
| Estimated Primary Completion Date: | June 2012 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: Reusable ECG leadwires-ICU
Current ECG leadwires will be used
|
Other: No intervention
usual care
|
|
Experimental: Disposable ECG leadwires-ICU
Covidien disposable ECG leadwires
|
Device: Disposable ECG leadwires; 5 and 6 lead sets
Disposable ECG leadwires used in ICU and telemetry monitoring
Other Name: Covidien disposable ECG lead wires
|
|
Active Comparator: Reusable Telemetry ECG leadwires
Usual care 6-lead ECG leadwire sets; reusable
|
Other: No intervention
usual care
|
|
Experimental: Disposable Telemetry ECG leadwires
Covidien disposable ECG leadwires (6 lead)- Telemetry
|
Device: Disposable ECG leadwires; 5 and 6 lead sets
Disposable ECG leadwires used in ICU and telemetry monitoring
Other Name: Covidien disposable ECG lead wires
|
Detailed Description:
Primary purposes: Using a randomized controlled trial methodology and randomizing similar (matched) intensive care units (ICU) to either disposable or cleaned, reusable ECG-LW: 1. Is there a difference in the rate of blood stream infection (BSI) and ventilator-associated pneumonia (VAP) in ICU environments (medical ICU, surgical ICU, cardiothoracic ICU, and neuroscience ICU) and surgical site infection (SSI); specifically, sternal wound infections in cardiothoracic ICU that utilize disposable vs. cleaned, reusable ECG-LW? 2. Is there a difference in ICU length of stay based on ECG-LW used: disposable vs. cleaned, reusable? 3. After controlling for patient age, comorbidity index and after removing patients who's date of BSI or VAP infections were within 48 hours of admission to the ICU, is there a difference in the rate of (A) blood stream infection (BSI), (B) ventilator-associated pneumonia (VAP) and (C) SSI in ICU environments (when applicable) that utilize disposable vs. cleaned, reusable ECG-LW? Secondary purposes: Using a randomized controlled trial methodology and randomizing similar telemetry units to either disposable or cleaned, reusable ECG-LW: 1. Is there a difference in the number of false/nuisance sightings/crisis calls (i.e., lead off, no telemetry, lead failure or other false alarms) identified by the Central Monitoring Unit (CMU)? 2. Is there a difference in true sightings/crisis calls identified by the CMU based on unit assignment of disposable or cleaned, reusable ECG-LW? 2b. If yes to #2, is there a difference in types of true sightings/calls identified by the CMUbased on assignment of disposable or cleaned, reusable ECG-LW?
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Primary HO: patients treated in an ICU setting; Secondary HO: Patients treated in cardiac telemetry setting
Exclusion Criteria:
- None
Contacts and Locations| Contact: Nancy M Albert, PhD | 216-444-7028 | albertn@ccf.org |
| Contact: Jennifer Forney, BSN, RN | 216-445-6462 | forneyj@ccf.org |
| United States, Ohio | |
| Cleveland Clinic | Recruiting |
| Cleveland, Ohio, United States, 44195 | |
| Contact: Nancy M Albert, PhD 216-444-7028 albertn@ccf.org | |
| Principal Investigator: Nancy M Albert, PhD | |
More Information
No publications provided
| Responsible Party: | Nancy M. Albert, Ph.D., Senior Director, Nursing Research and Innovation, The Cleveland Clinic |
| ClinicalTrials.gov Identifier: | NCT01411553 History of Changes |
| Other Study ID Numbers: | clevelandCF |
| Study First Received: | August 5, 2011 |
| Last Updated: | March 30, 2012 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by The Cleveland Clinic:
|
ICU Telemetry ECG lead wire monitoring Infection Nuisance alarms |
ClinicalTrials.gov processed this record on June 18, 2013